David Templeton
Chief Tech/Sci/R&D Officer presso N4 PHARMA PLC
Patrimonio netto: - $ in data 31/03/2024
Profilo
David Templeton is currently the Executive Director & Technical Director at N4 Pharma Plc since 2019.
Previously, he worked as the Director-Clinical Pharmacology at Eisai Ltd.
(United Kingdom) from 2007 to 2010 and as the Head-Non Clinical Development at Celltech Ltd.
from 2003 to 2004.
He also held the position of Head-Biometrics at Merck Generics Ltd.
Partecipazioni note in società pubbliche
Società | Data | Numero di azioni | Valorizzazione | Data di valutazione |
---|---|---|---|---|
N4 PHARMA PLC
-.--% | 31/12/2022 | 0 ( -.--% ) | - $ | 31/03/2024 |
Posizioni attive di David Templeton
Società | Posizione | Inizio |
---|---|---|
N4 PHARMA PLC | Chief Tech/Sci/R&D Officer | 21/05/2019 |
Precedenti posizioni note di David Templeton
Società | Posizione | Fine |
---|---|---|
Eisai Ltd. (United Kingdom)
Eisai Ltd. (United Kingdom) Pharmaceuticals: MajorHealth Technology Eisai Ltd. (United Kingdom) is a pharmaceutical company based in Hatfield, UK. Part of Eisai Co., Ltd., Eisai Ltd. prioritizes patients and their families by continually improving the benefits that healthcare can provide. The British company was founded in 1988 and Gary Bryan Hendler has been the CEO of the company since 2008. | Corporate Officer/Principal | 01/01/2010 |
Celltech Ltd.
Celltech Ltd. Miscellaneous Commercial ServicesCommercial Services Celltech Ltd. provides research and development on natural science and engineering. The company was founded in 1999 and is headquartered in Slough, GB. | Corporate Officer/Principal | 01/01/2004 |
Merck Generics Ltd.
Merck Generics Ltd. Pharmaceuticals: MajorHealth Technology Merck Generics Ltd. provides therapies and drug products. The private company is based in London, UK. | Corporate Officer/Principal | - |
Esperienze
Posizioni ricoperte
Attive
Inattive
Società quotate in Borsa
Aziende private
Relazioni
Relazioni di 1° grado
Aziende connesse in 1º grado
Uomo
Donna
Amministratori
Dirigenti
Società collegate
Società quotate in Borsa | 1 |
---|---|
N4 PHARMA PLC | Health Technology |
Aziende private | 3 |
---|---|
Eisai Ltd. (United Kingdom)
Eisai Ltd. (United Kingdom) Pharmaceuticals: MajorHealth Technology Eisai Ltd. (United Kingdom) is a pharmaceutical company based in Hatfield, UK. Part of Eisai Co., Ltd., Eisai Ltd. prioritizes patients and their families by continually improving the benefits that healthcare can provide. The British company was founded in 1988 and Gary Bryan Hendler has been the CEO of the company since 2008. | Health Technology |
Celltech Ltd.
Celltech Ltd. Miscellaneous Commercial ServicesCommercial Services Celltech Ltd. provides research and development on natural science and engineering. The company was founded in 1999 and is headquartered in Slough, GB. | Commercial Services |
Merck Generics Ltd.
Merck Generics Ltd. Pharmaceuticals: MajorHealth Technology Merck Generics Ltd. provides therapies and drug products. The private company is based in London, UK. | Health Technology |
- Borsa valori
- Insiders
- David Templeton